PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Magnum Experiment 27
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


JEL.F 36.9%NBPE.L 18.96%MLERO.PA 7.76%PME.AX 6.58%GFRD.L 6.03%NVDA 5.22%WELL.TO 3.49%OLA.TO 3.41%XAU.TO 2.92%BGL.AX 2.91%DLCG.TO 2.56%CELH 1.59%EquityEquity
PositionCategory/SectorTarget Weight
APLD
Applied Digital Corporation
Financial Services
0.63%
BGL.AX
Bellevue Gold Limited
Basic Materials
2.91%
CCEP.L
Coca-Cola Europacific Partners plc
Consumer Defensive
0.76%
CELH
Celsius Holdings, Inc.
Consumer Defensive
1.59%
DLCG.TO
Dominion Lending Centres Inc.
Financial Services
2.56%
FDY.TO
Faraday Copper Corp.
Basic Materials
0.29%
GFRD.L
Galliford Try plc
Industrials
6.03%
JEL.F
JEOL Ltd
Technology
36.90%
MLERO.PA
Euroland Corporate Société anonyme
Financial Services
7.76%
NBPE.L
NB Private Equity Partners Ltd
Financial Services
18.96%
NVDA
NVIDIA Corporation
Technology
5.22%
OLA.TO
Orla Mining Ltd.
Basic Materials
3.41%
PME.AX
Pro Medicus Limited
Healthcare
6.58%
WELL.TO
WELL Health Technologies Corp.
Healthcare
3.49%
XAU.TO
Goldmoney Inc.
Financial Services
2.92%

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Magnum Experiment 27, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.


0.00%50,000.00%100,000.00%150,000.00%NovemberDecember2025FebruaryMarchApril
123,864.58%
202.82%
Magnum Experiment 27
Benchmark (^GSPC)
Portfolio components

The earliest data available for this chart is Oct 18, 2013, corresponding to the inception date of CCEP.L

Returns By Period

As of Apr 18, 2025, the Magnum Experiment 27 returned -2.81% Year-To-Date and 355.00% of annualized return in the last 10 years.


YTD1M6M1Y5Y*10Y*
^GSPC
S&P 500
-10.18%-5.91%-9.57%5.19%12.98%9.68%
Magnum Experiment 277.54%-2.14%-15.46%2.30%-2.99%91.67%
APLD
Applied Digital Corporation
-48.30%-43.65%-50.31%64.58%97.58%43.37%
BGL.AX
Bellevue Gold Limited
-9.57%-25.32%-35.84%-48.65%12.72%62.85%
CCEP.L
Coca-Cola Europacific Partners plc
17.95%6.51%23.02%39.48%19.25%11.48%
CELH
Celsius Holdings, Inc.
41.38%22.62%15.72%-47.53%87.75%51.42%
DLCG.TO
Dominion Lending Centres Inc.
7.55%4.92%66.60%172.03%67.06%53.67%
FDY.TO
Faraday Copper Corp.
10.98%-9.27%-11.49%4.85%33.72%137.14%
GFRD.L
Galliford Try plc
4.06%9.33%8.98%73.46%30.84%61.68%
JEL.F
JEOL Ltd
-11.83%-7.45%-14.28%-29.18%3.01%12.79%
MLERO.PA
Euroland Corporate Société anonyme
14.47%3.13%30.93%44.30%37.52%27.95%
NBPE.L
NB Private Equity Partners Ltd
1.75%-1.98%-0.12%1.96%16.98%63.34%
NVDA
NVIDIA Corporation
-24.42%-12.08%-25.87%20.80%67.11%66.91%
OLA.TO
Orla Mining Ltd.
103.86%23.73%141.31%188.83%44.02%66.35%
PME.AX
Pro Medicus Limited
-14.38%-10.68%3.71%105.87%52.13%59.46%
WELL.TO
WELL Health Technologies Corp.
-39.99%-20.83%-2.51%77.34%102.06%129.54%
XAU.TO
Goldmoney Inc.
8.68%0.01%-19.17%-2.51%-8.36%197.42%
*Annualized

Monthly Returns

The table below presents the monthly returns of Magnum Experiment 27, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20255.96%-1.62%-0.75%3.94%7.54%
2024-2.28%-4.07%10.22%-1.16%2.89%-1.73%-2.69%12.89%11.51%0.62%-14.71%-8.98%-1.20%
202313.46%8.05%-1.17%8.11%-8.31%-4.93%8.67%-7.69%-14.69%4.22%-2.67%1.39%0.51%
2022-4.07%11.11%-4.84%-5.21%-14.00%-3.73%-6.24%-7.06%2.17%5.66%9.02%-5.11%-22.54%
202127.91%3.75%-0.55%-3.43%-2.02%-7.58%5.66%-4.39%-12.49%10.18%-10.97%-5.73%-5.67%
2020-2.95%-5.44%45.92%-4.12%-9.56%12.99%-14.99%37.96%-19.37%-8.14%11.19%6.88%35.44%
20190.41%-0.20%50.34%-5.02%-24.32%19.22%1.66%-6.49%2.25%-1.93%-11.92%5.11%13.95%
2018-23.80%-23.11%-8.59%-1.96%-6.53%-6.63%4.14%-10.08%-8.34%-5.32%-13.10%-16.87%-73.10%
20173.43%1.77%-4.60%-2.24%2.87%-6.49%-6.93%48.56%24.23%29.62%0.69%-0.94%109.69%
2016-2.69%29.65%-16.27%13.89%20.44%-15.79%4.83%-10.39%4.69%-4.76%-21.31%-3.97%-13.63%
201515.42%-1.01%10.05%3.36%147,115.96%23.30%7.86%-13.95%-40.31%24.24%33.99%-22.23%169,062.28%
2014-0.37%-5.93%7.13%-0.39%-6.71%7.20%12.08%16.87%-6.10%-2.13%2.15%-1.37%21.31%

Expense Ratio

Magnum Experiment 27 has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


The portfolio doesn't include any funds that charge management fees.

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of Magnum Experiment 27 is 67, indicating average performance compared to other portfolios on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of Magnum Experiment 27 is 6767
Overall Rank
The Sharpe Ratio Rank of Magnum Experiment 27 is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of Magnum Experiment 27 is 6565
Sortino Ratio Rank
The Omega Ratio Rank of Magnum Experiment 27 is 6666
Omega Ratio Rank
The Calmar Ratio Rank of Magnum Experiment 27 is 7373
Calmar Ratio Rank
The Martin Ratio Rank of Magnum Experiment 27 is 6767
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for Portfolio, currently valued at 0.07, compared to the broader market-4.00-2.000.002.00
Portfolio: 0.07
^GSPC: 0.24
The chart of Sortino ratio for Portfolio, currently valued at 0.31, compared to the broader market-6.00-4.00-2.000.002.004.00
Portfolio: 0.31
^GSPC: 0.47
The chart of Omega ratio for Portfolio, currently valued at 1.04, compared to the broader market0.400.600.801.001.201.401.60
Portfolio: 1.04
^GSPC: 1.07
The chart of Calmar ratio for Portfolio, currently valued at 0.03, compared to the broader market0.001.002.003.004.005.006.00
Portfolio: 0.03
^GSPC: 0.24
The chart of Martin ratio for Portfolio, currently valued at 0.16, compared to the broader market0.005.0010.0015.0020.00
Portfolio: 0.16
^GSPC: 1.08

Portfolio components
Sharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
APLD
Applied Digital Corporation
0.241.471.180.381.33
BGL.AX
Bellevue Gold Limited
-0.75-0.850.88-0.75-1.23
CCEP.L
Coca-Cola Europacific Partners plc
1.171.721.213.196.61
CELH
Celsius Holdings, Inc.
-0.73-1.040.88-0.63-0.81
DLCG.TO
Dominion Lending Centres Inc.
3.293.831.503.3924.67
FDY.TO
Faraday Copper Corp.
-0.060.221.03-0.06-0.17
GFRD.L
Galliford Try plc
1.932.831.334.2410.96
JEL.F
JEOL Ltd
-0.47-0.430.95-0.30-1.09
MLERO.PA
Euroland Corporate Société anonyme
0.330.941.160.883.18
NBPE.L
NB Private Equity Partners Ltd
0.010.191.030.010.03
NVDA
NVIDIA Corporation
0.270.781.100.431.17
OLA.TO
Orla Mining Ltd.
3.613.741.484.5722.62
PME.AX
Pro Medicus Limited
1.962.291.341.967.74
WELL.TO
WELL Health Technologies Corp.
1.402.191.291.645.11
XAU.TO
Goldmoney Inc.
-0.020.251.03-0.01-0.04

The current Magnum Experiment 27 Sharpe ratio is 0.62. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Compared to the broad market, where average Sharpe ratios range from 0.21 to 0.77, this portfolio's current Sharpe ratio lies between the 25th and 75th percentiles. This indicates that the its risk-adjusted performance is in line with the majority of portfolios. This suggests a balanced approach to risk and return, which might be suitable for a broad range of investors.

Use the chart below to compare the Sharpe ratio of Magnum Experiment 27 with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.07
0.24
Magnum Experiment 27
Benchmark (^GSPC)
Portfolio components

Dividends

Dividend yield

Magnum Experiment 27 provided a 1.61% dividend yield over the last twelve months.


TTM20242023202220212020201920182017201620152014
Portfolio1.61%1.51%2.08%1.80%1.05%5.90%62,419.59%8.65%5.39%67.60%74.92%65.96%
APLD
Applied Digital Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BGL.AX
Bellevue Gold Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%59.09%48.39%92.44%
CCEP.L
Coca-Cola Europacific Partners plc
0.03%0.03%0.04%0.04%0.03%0.02%0.03%0.03%0.03%0.02%0.00%0.00%
CELH
Celsius Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DLCG.TO
Dominion Lending Centres Inc.
0.74%1.15%4.29%2.81%0.00%0.00%0.00%4.00%2.13%0.00%116.00%0.00%
FDY.TO
Faraday Copper Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%112.86%196.43%372.78%262.33%
GFRD.L
Galliford Try plc
4.53%3.99%10.00%5.03%2.61%80.96%64.03%113.00%70.84%60.27%42.31%39.05%
JEL.F
JEOL Ltd
0.01%0.01%0.01%0.01%0.00%0.00%0.00%0.00%0.01%0.01%0.00%0.01%
MLERO.PA
Euroland Corporate Société anonyme
4.52%4.71%6.84%7.02%4.40%3.33%7.79%11.88%0.00%0.00%0.00%37.50%
NBPE.L
NB Private Equity Partners Ltd
4.97%4.50%4.30%4.47%2.82%3.82%3.78%3.96%3.62%324.88%352.24%300.76%
NVDA
NVIDIA Corporation
0.03%0.02%0.03%0.11%0.05%0.12%0.27%0.46%0.29%0.45%1.20%1.70%
OLA.TO
Orla Mining Ltd.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PME.AX
Pro Medicus Limited
0.23%0.16%0.31%0.40%0.24%0.35%0.31%0.55%0.46%0.62%0.60%1.83%
WELL.TO
WELL Health Technologies Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XAU.TO
Goldmoney Inc.
0.00%0.00%0.00%0.00%0.00%0.00%2,139,037.43%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-73.66%
-14.02%
Magnum Experiment 27
Benchmark (^GSPC)
Portfolio components

Worst Drawdowns

The table below displays the maximum drawdowns of the Magnum Experiment 27. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Magnum Experiment 27 was 81.66%, occurring on Mar 12, 2020. The portfolio has not yet recovered.

The current Magnum Experiment 27 drawdown is 7.33%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-81.66%Dec 8, 2017582Mar 12, 2020
-63.81%May 20, 201595Sep 29, 2015543Nov 3, 2017638
-21.24%Nov 7, 20177Nov 15, 201716Dec 7, 201723
-14.91%Jan 20, 201427Feb 25, 2014101Jul 17, 2014128
-13.79%Aug 26, 201436Oct 14, 201473Jan 27, 2015109

Volatility

Volatility Chart

The current Magnum Experiment 27 volatility is 9.60%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
9.60%
13.60%
Magnum Experiment 27
Benchmark (^GSPC)
Portfolio components

Diversification

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

MLERO.PADLCG.TOAPLDCCEP.LBGL.AXJEL.FXAU.TOCELHPME.AXOLA.TOFDY.TOGFRD.LNVDANBPE.LWELL.TO
MLERO.PA1.000.010.020.050.010.000.010.020.010.020.030.080.010.02-0.01
DLCG.TO0.011.000.040.040.030.030.040.050.080.070.120.090.080.090.08
APLD0.020.041.000.020.040.060.040.110.070.080.060.050.130.060.12
CCEP.L0.050.040.021.000.060.070.050.090.090.030.090.080.040.120.09
BGL.AX0.010.030.040.061.000.080.070.050.120.090.090.050.060.100.09
JEL.F0.000.030.060.070.081.000.040.030.180.090.020.110.040.160.07
XAU.TO0.010.040.040.050.070.041.000.050.070.150.110.080.060.070.16
CELH0.020.050.110.090.050.030.051.000.040.070.070.080.220.080.17
PME.AX0.010.080.070.090.120.180.070.041.000.080.080.080.100.150.12
OLA.TO0.020.070.080.030.090.090.150.070.081.000.110.050.110.130.18
FDY.TO0.030.120.060.090.090.020.110.070.080.111.000.120.120.130.16
GFRD.L0.080.090.050.080.050.110.080.080.080.050.121.000.100.240.12
NVDA0.010.080.130.040.060.040.060.220.100.110.120.101.000.140.25
NBPE.L0.020.090.060.120.100.160.070.080.150.130.130.240.141.000.18
WELL.TO-0.010.080.120.090.090.070.160.170.120.180.160.120.250.181.00
The correlation results are calculated based on daily price changes starting from Oct 21, 2013
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab